Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction
Idioma
EN
Article de revue
Este ítem está publicado en
Journal of the European Academy of Dermatology and Venereology. 2020, vol. 34, n° 8, p. e430-e431
Palabras clave
PharmacoEpi-Drugs
Centros de investigación